Financials

News Discussions Technicals Forecast Seasonals

6996 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company, which engages in oncology medicines, R&D capabilities, and differentiated strategic approach to developing novel oncology therapies. It operates in the segments of the pharmaceutical, biotechnology and other related markets that address oncology diseases. The company was founded by Jian Ming Mei on August 28, 2018, and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6996 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company